Cluster differentiation (CD166), also known as active leukocyte cell adhesion molecule (ALCAM), is a transmembrane glycoprotein that is involved in a variety of biological functions such as cell adhesion, migration, and signaling [7]. CD166 appears to be implicated in cancer progression and metastasis, making it a possible candidate for detecting high-risk breast cancer patients [8-9]. Here, ALCAM is linked to breast carcinoma.